Cite
HARVARD Citation
Mithraprabhu, S. et al. (2021). Phase II trial of single‐agent panobinostat consolidation improves responses after sub‐optimal transplant outcomes in multiple myeloma. British journal of haematology. pp. 160-170. [Online].